Article
CCND1 G870A polymorphism and risk for head and neck cancer: a meta-analysis.
Medical oncology (Northwood, London, England) - 1 Dec 2011
Tang Chunbo, Wang Zhanwei, Yu Jinhua, Wu Yunong, Zhu Zhijun, Chen Ning
Abstract excerpt
CCND1 plays a critical role in cell cycle control and may contribute to head and neck cancer. We performed a meta-analysis of eleven case-control studies that examined the association between CCND1 G870A polymorphism and head and neck cancer risk. Overall, no significant association of this polymorphism with head and neck cancer was found (for AA vs. GG: OR=0.96, 95% CI=0.59-1.58, P<0.01 for heterogeneity; for GA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
